← FDA Drug Approvals (Drugs@FDA)
MEMANTINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS LTD · Approved 2022-08-11
Drug application
- FDA Application #
ANDA214731- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MEMANTINE HYDROCHLORIDE
- Generic name
- Memantine Hydrochloride
- Active ingredients
- MEMANTINE HYDROCHLORIDE
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- NOVAST LABS LTD
- First approval
- 2022-08-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown